8-KEarnings & ResultsExhibits & Filings

ALNYLAM PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 4, 2010)

Filed August 4, 2010For Securities:ALNY

Summary

Alnylam Pharmaceuticals, Inc. (ALNY) filed an 8-K on August 4, 2010, primarily to announce its financial results for the quarter ended June 30, 2010. The report itself is concise, as the detailed financial information and operational updates are contained within the furnished press release (Exhibit 99.1). For investors, this filing serves as a key update on the company's performance during the second quarter of 2010. While the 8-K doesn't provide the specific financial figures directly, it directs stakeholders to the press release for a comprehensive overview of revenue, expenses, net income/loss, and any significant business developments or pipeline progress announced during that period. Investors should review Exhibit 99.1 for the substantive information regarding Alnylam's financial condition and operational results.

Key Highlights

  • 1Announcement of Q2 2010 financial results for Alnylam Pharmaceuticals, Inc.
  • 2Key financial and operational details are provided in an accompanying press release (Exhibit 99.1).
  • 3The filing is made under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
  • 4This report acts as a notification mechanism for investors regarding the company's quarterly performance.
  • 5Information furnished in this 8-K is not considered 'filed' for certain SEC liability purposes unless specifically incorporated into other filings.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce Alnylam Pharmaceuticals, Inc.'s financial results for the quarter ended June 30, 2010, and to furnish the associated press release containing these details.

The detailed financial results and operational updates for the quarter ended June 30, 2010, are provided in the press release furnished as Exhibit 99.1 to this 8-K filing.

No, the 8-K form itself does not contain the specific financial figures. These are detailed in the press release (Exhibit 99.1) which is referenced in the filing.

This means that the information in the 8-K (specifically the press release) is being provided to the public but is not subject to the same level of liability under Section 18 of the Exchange Act as information that is formally 'filed'. However, it can still be incorporated by reference into other SEC filings where liability would apply.